Dm Disease-A-Month最新文献_第2页

Title Page 标题页

IF 3.8 3区医学

Dm Disease-A-Month Pub Date : 2024-08-01 DOI: 10.1016/S0011-5029(24)00113-5

引用次数: 0

Foreword: Progressive supranuclear palsy: Neuropathology, clinical presentation, diagnostic challenges, management, and emerging therapies 前言：进行性核上性麻痹：神经病理学、临床表现、诊断难题、管理和新兴疗法。

IF 3.8 3区医学

Dm Disease-A-Month Pub Date : 2024-08-01 DOI: 10.1016/j.disamonth.2024.101752

引用次数: 0

Information for Readers 读者信息

IF 3.8 3区医学

Dm Disease-A-Month Pub Date : 2024-08-01 DOI: 10.1016/S0011-5029(24)00114-7

引用次数: 0

Progressive supranuclear palsy: Neuropathology, clinical presentation, diagnostic challenges, management, and emerging therapies 进行性核上性麻痹：神经病理学、临床表现、诊断难题、管理和新兴疗法。

IF 3.8 3区医学

Dm Disease-A-Month Pub Date : 2024-08-01 DOI: 10.1016/j.disamonth.2024.101753

{"title":"Progressive supranuclear palsy: Neuropathology, clinical presentation, diagnostic challenges, management, and emerging therapies","authors":"","doi":"10.1016/j.disamonth.2024.101753","DOIUrl":"10.1016/j.disamonth.2024.101753","url":null,"abstract":"<div><p>Progressive supranuclear palsy (PSP) is a neurodegenerative disease characterized by the accumulation of 4R-tau protein aggregates in various brain regions. PSP leads to neuronal loss, gliosis, and tau-positive inclusions, such as neurofibrillary tangles, tufted astrocytes, and coiled bodies. These pathological changes mainly affect the brainstem and the basal ganglia, resulting in distinctive MRI features, such as the hummingbird and morning glory signs. PSP shows clinical heterogeneity and presents as different phenotypes, the most classical of which is Richardson's syndrome (PSP-RS). The region of involvement and the mode of atrophy spread can further distinguish subtypes of PSP. PSP patients can experience various signs and symptoms, such as postural instability, supranuclear ophthalmoplegia, low amplitude fast finger tapping, and irregular sleep patterns. The most common symptoms of PSP are postural instability, falls, vertical gaze palsy, bradykinesia, and cognitive impairment. These features often overlap with those of Parkinson's disease (PD) and other Parkinsonian syndromes, making the diagnosis challenging. PSP is an essential clinical topic to research because it is a devastating and incurable disease. However, there are still many gaps in knowledge about its pathophysiology, diagnosis, and treatment. Several clinical trials are underway to test noveltherapies that target tau in various ways, such as modulating its post-translational modifications, stabilizing its interaction with microtubules, or enhancing its clearance by immunotherapy. These approaches may offer new hope for slowing down the progression of PSP. In this review, we aim to provide an overview of the current knowledge on PSP, from its pathogenesis to its management. We also discuss the latest advances and future directions in PSP research.</p></div>","PeriodicalId":51017,"journal":{"name":"Dm Disease-A-Month","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141441108","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

C2: Editorial Board C2：编辑委员会

IF 3.8 3区医学

Dm Disease-A-Month Pub Date : 2024-08-01 DOI: 10.1016/S0011-5029(24)00112-3

引用次数: 0

The prognostic significance of pro-BNP and heart failure in acute pulmonary embolism: A systematic review Pro-BNP 和急性肺栓塞心衰的预后意义：系统综述。

IF 3.8 3区医学

Dm Disease-A-Month Pub Date : 2024-07-02 DOI: 10.1016/j.disamonth.2024.101783

{"title":"The prognostic significance of pro-BNP and heart failure in acute pulmonary embolism: A systematic review","authors":"","doi":"10.1016/j.disamonth.2024.101783","DOIUrl":"10.1016/j.disamonth.2024.101783","url":null,"abstract":"<div><p>Pulmonary embolism<span><span> (PE) is the third most common type of cardiovascular disease and carries a high mortality rate<span> of 30% if left untreated. Although it is commonly known that individuals who suffer heart failure (HF) are more likely to experience a pulmonary embolism, little is known concerning the prognostic relationship between acute PE and HF. This study aims to evaluate the prognostic usefulness of heart failure and pro-BNP in pulmonary embolism cases. A scientific literature search, including </span></span>PubMed<span><span>, Medline, and Cochrane reviews, was used to assess and evaluate the most pertinent research that has been published. The findings showed that increased N-terminal brain natriuretic peptide (NT-proBNP) levels could potentially identify pulmonary embolism patients with worse immediate prognoses and were highly predictive of all-cause death. Important prognostic information can be obtained from NT-proBNP and Heart-type Fatty Acid Binding Proteins (H-FABP) when examining individuals with PE. The heart, distal tubular cells of the renal system, and </span>skeletal muscle are where H-FABP is primarily found, with myocardial cells having the highest concentration. Recent studies have indicated that these biomarkers may also help assess the severity of PE and its long-term risk.</span></span></p></div>","PeriodicalId":51017,"journal":{"name":"Dm Disease-A-Month","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141494189","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The role of biomarkers in the prognosis and risk stratification in heart failure: A systematic review 生物标志物在心衰预后和风险分层中的作用：系统综述。

IF 3.8 3区医学

Dm Disease-A-Month Pub Date : 2024-07-02 DOI: 10.1016/j.disamonth.2024.101782

{"title":"The role of biomarkers in the prognosis and risk stratification in heart failure: A systematic review","authors":"","doi":"10.1016/j.disamonth.2024.101782","DOIUrl":"10.1016/j.disamonth.2024.101782","url":null,"abstract":"<div><p><span><span><span><span>Acute heart failure (AHF) episodes are marked by high rates of morbidity and mortality during the episode and minimal advancements in its care. Multiple biomarker monitoring is now a crucial supplementary technique in the therapy of AHF. A scientific literature search was conducted by assessing and evaluating the most pertinent research that has been published, including original papers and review papers with the use of </span>PubMed, Medline, and </span>Cochrane databases<span><span>. Established biomarkers like natriuretic peptides (BNP, NT-proBNP) and </span>cardiac troponins<span> play crucial roles in diagnostic and prognostic evaluation. Emerging biomarkers such as microRNAs, </span></span></span>osteopontin<span>, galectin-3, ST2<span>, and GDF-15 show promise in enhancing risk stratification and predicting </span></span></span>adverse outcomes in HF. However, while these biomarkers offer valuable insights, their clinical utility requires further validation and integration into practice. Continued research into novel biomarkers holds promise for early HF detection and risk assessment, potentially mitigating the global burden of HF. Understanding the nuances of biomarker utilization is crucial for their effective incorporation into clinical practice, ultimately improving HF management and patient care.</p></div>","PeriodicalId":51017,"journal":{"name":"Dm Disease-A-Month","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141494190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The role of exercise training and dietary sodium restriction in heart failure rehabilitation: A systematic review 运动训练和饮食限钠在心力衰竭康复中的作用：系统综述。

IF 3.8 3区医学

Dm Disease-A-Month Pub Date : 2024-07-02 DOI: 10.1016/j.disamonth.2024.101781

{"title":"The role of exercise training and dietary sodium restriction in heart failure rehabilitation: A systematic review","authors":"","doi":"10.1016/j.disamonth.2024.101781","DOIUrl":"10.1016/j.disamonth.2024.101781","url":null,"abstract":"<div><p><span>Heart failure (HF) rehabilitation seeks to enhance the entire well-being and quality of life of those with HF by focusing on both physical and mental health. Non-pharmacological measures, particularly exercise training, and dietary salt reduction, are essential components of heart failure rehabilitation. This study examines the impact of these components on the recovery of patients with heart failure. By conducting a comprehensive analysis of research articles published from 2010 to 2024, we examined seven relevant studies collected from sources that include PubMed and Cochrane reviews. Our findings indicate that engaging in physical activity leads to favorable modifications in the heart, including improved </span>heart contractility<span>, vasodilation<span>, and cardiac output. These alterations enhance the delivery of oxygen to the peripheral tissues and reduce symptoms of heart failure, such as fatigue and difficulty breathing. Nevertheless, decreasing the consumption of salt in one's diet to less than 1500 mg per day did not have a substantial impact on the frequency of hospitalizations, visits to the emergency room, or overall mortality when compared to conventional treatment. The combination of sodium restriction and exercise training can have synergistic effects due to their complementary modes of action. Exercise improves cardiovascular health and skeletal muscle metabolism, while sodium restriction increases fluid balance and activates neurohormonal pathways. Therefore, the simultaneous usage of both applications may result in more significant enhancements in HF symptoms and clinical outcomes compared to using each program alone.</span></span></p></div>","PeriodicalId":51017,"journal":{"name":"Dm Disease-A-Month","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141499543","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Forword: Heart failure and other selected issues in cardiac pathology 前言：心力衰竭及其他心脏病理学选题。

IF 3.8 3区医学

Dm Disease-A-Month Pub Date : 2024-06-29 DOI: 10.1016/j.disamonth.2024.101779

引用次数: 0

Cardiovascular complications during pregnancy: Advancing cardio-obstetrics 孕期心血管并发症：推进心血管产科的发展。

IF 3.8 3区医学

Dm Disease-A-Month Pub Date : 2024-06-22 DOI: 10.1016/j.disamonth.2024.101780

{"title":"Cardiovascular complications during pregnancy: Advancing cardio-obstetrics","authors":"","doi":"10.1016/j.disamonth.2024.101780","DOIUrl":"10.1016/j.disamonth.2024.101780","url":null,"abstract":"<div><p>As the incidence of cardiovascular diseases (CVDs) continues to rise among women of childbearing age, the pregnant population with pre-existing heart conditions presents a complex and heterogeneous profile. These women face varying degrees of risk concerning maternal cardiovascular, obstetric, and fetal complications. Effectively managing adverse cardiovascular events during pregnancy presents substantial clinical challenges. The uncertainties surrounding diagnostic and therapeutic approaches create a dynamic landscape with potential implications for maternal and fetal health. Cardio-obstetrics has become increasingly recognized as a vital multidisciplinary field necessitating a collaborative approach to managing cardiovascular conditions during pregnancy. In this review, we aim to provide a thorough and up-to-date examination of the existing evidence, offering a comprehensive overview of strategies and considerations in the management of cardiovascular complications during pregnancy. Special emphasis is placed on the safety assessment of diagnostic procedures and the exploration of treatment options designed to prioritize the well-being of the mother and fetus. We also explore the significance of a multidisciplinary cardio-obstetrics team in providing comprehensive care for women of childbearing age with or at risk for CVD.</p></div>","PeriodicalId":51017,"journal":{"name":"Dm Disease-A-Month","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0011502924001068/pdfft?md5=2c5a8efac69431932bd56b793af16aab&pid=1-s2.0-S0011502924001068-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141443690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0